MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Longitudinal CSF-profile and brain pathology mirrors clinical course of LRRK2-Related Parkinson’s Disease

    I. Wurster, S. Lerche, I. Lachmann, M. Neumann, T. Gasser, K. Brockmann (Tübingen, Germany)

    Objective: Do clinical cognitive profiles and CSF characterisitcs of Abeta1_42, total-tau, phospho-tau and alpha-synuclein during lifetime correspond to histopathological findings post-mortem in LRKK2-associated Parkinson’s disease…
  • 2019 International Congress

    Auditory-Perceptual Voice and Speech Evaluation in ATP1A3-positive Patients

    M. Finger, L. Madden, K. Ruckart, K. Downes, J. Cook, B. Snively, A. Brashear, I. Haq (Winston-Salem, NC, USA)

    Objective: To characterize speech and voice dysfunctions in ATP1A3 mutation positive individuals compared to concurrent mutation negative family controls. Background: Bulbar symptoms are frequent in…
  • 2019 International Congress

    NKX2-1-Related Disorder with Cerebral Folate Deficiency

    J. Maclean, Q. Luc, L. Ramos-Platt, S. Saitta, C. Quindipan (Los Angeles, CA, USA)

    Objective: To describe a patient with a de novo NKX2-1 mutation and low CSF 5-methyltetrahydrofolate (5MTHF) who had mild improvement in fine motor control after…
  • 2019 International Congress

    Looking “cherry red spot myoclonus” in the eyes

    GM. Riboldi, J. Martone, JR. Rizzo, T. Hudson, S. Frucht, J. Rucker (New York, NY, USA)

    Objective: To describe eye movements in a cohort of patients affected with Sialidosis type 1. Background: Sialidosis, or Mucolipidosis type 1, is a rare autosomal…
  • 2019 International Congress

    Investigating the impact of a-synuclein pathology on human embryonic stem cell derived dopaminergic neurons transplanted in an accelerated a-synuclein rat model of Parkinson’s disease

    D. Hoban, S. Shrigley, L. Breger, J. Nelander Wahlestedt, T. Cardoso, B. Mattsson, K. Luk, M. Parmar, A. Björklund (Lund, Sweden)

    Objective: In this study, we assess how transplanted human embryonic stem cell (hESC) derived dopaminergic (DA) neurons survive, mature, integrate and innervate the host circuitry…
  • 2019 International Congress

    REM density in isolated REM sleep without atonia

    F. Dijkstra, M. Viaene, I. de Volder, P. Cras, D. Crosiers (Geel, Belgium)

    Objective: To investigate REM density in patients with isolated REM sleep without atonia. Background: Isolated RSWA (iRSWA) is regarded as a prodromal phase of REM…
  • 2019 International Congress

    Treatment of dopaminergic augmented RLS with Ecopipam, A D1 specific antagonist: an exploratory placebo controlled cross-over trial

    O. Titlayo, W. Ondo (Houston, TX, USA)

    Objective: To establish initial safety and preliminary efficacy of ecopipam, a D1 specific antagonist in patients currently taking dopamine agonist and demonstrating augmentation. Background: Dopamine…
  • 2019 International Congress

    What patients need – a qualitative analysis of consultations prior to deep brain stimulation in patients with Parkinson’s disease

    R. Dano, JN. Petry-Schmelzer, J. Steffen, G. Fink, M. Barbe (Cologne, Germany)

    Objective: To evaluate the different needs of patients with Parkinson’s disease (PD) prior to deep brain stimulation (DBS). Background: DBS is a well established and…
  • 2019 International Congress

    Correlation between degree of dysarthria, motor severity and quality of life in patients with Parkinson’s disease

    M. Olchik, C. Rieder, L. Scudeiro, R. Rech, R. Millette, A. Ayres (Porto Alegre, Brazil)

    Objective: To verify the relationship between clinical findings regarding dysarthria and self-perception of PD patients. Background: Dysarthria is one of the most common non-motor symptoms…
  • 2019 International Congress

    Caregiver support and its association with advanced Parkinson’s disease and clinical outcomes

    A. Fasano, L. Bergmann, V. Fung, Y. Jalundhwala, K. Onuk, Z. Pirtosek, W. Robieson, K. Seppi, A. Takáts, P. Martinez-Martin (Totronto, ON, Canada)

    Objective: To assess characteristics of advanced Parkinson’s disease (APD) patients with ongoing device-aided treatment stratified by caregiver support. Background: Observe-PD is a multicountry, cross-sectional observational…
  • « Previous Page
  • 1
  • …
  • 151
  • 152
  • 153
  • 154
  • 155
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley